PATHOLOGY PEER REVIEW AND PATHOLOGY SUPPORT FOR THE DNTP AND DIR AT NIEHS" CHARLES RIVER LABORATORIES (CRL)
NIEHS 查尔斯河实验室 (CRL) 的 DNTP 和 DIR 的病理学同行评审和病理学支持
基本信息
- 批准号:10241886
- 负责人:
- 金额:$ 254.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-24 至 2021-08-23
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsApoptosisAutopsyCell ProliferationChemicalsConsultContractsDNADNA sequencingDataDevelopmentElectron MicroscopyEnsureEnvironmental ExposureEvaluationExposure toGenotypeGoalsGovernmentHazard IdentificationHistologyImmunohistochemistryIn SituIn Situ HybridizationJournalsLaboratoriesLaboratory Animal MedicineLaboratory AnimalsMalignant NeoplasmsManuscriptsMolecular BiologyMolecular and Cellular BiologyMorphologyNational Institute of Environmental Health SciencesNational Toxicology ProgramPathologicPathologyPeer ReviewPersonsPreparationProceduresPublic HealthPublicationsRNAReportingResearch DesignResearch PersonnelRiversServicesSiteSlideSpecimenStainsSupport ContractsTechniquesTimeTissuesToxic effectTrainingWorkbasecarcinogenicitydevelopmental toxicitydisorder preventionimmunotoxicitymolecular pathologypostersreproductive toxicityresearch studyworking group
项目摘要
The subject contract was established to provide a broad range of routine and specialized pathology services in support of studies conducted under contract by the National Toxicology Program (NTP) and for supplemental studies on pathology specimens generated through these studies. The contract also provides critical pathology (including molecular pathology) support for studies conducted by in-house investigators at NIEHS and other NIEHS contract studies. Specifically, the following services are supported by this contract: 1) necropsy and in-house necropsy assistance; 2) histology (tissue trimming and processing, slide preparation, and staining); 3) histopathological evaluation/interpretation; 4) application of specialized qualitative and quantitative morphological procedures (immunohistochemistry, morphometrics, cell proliferation, apoptosis, electron microscopy); 5) adaptation, development, refinement, application of new techniques in cellular and molecular biology including (but not limited to) genotyping, DNA sequencing, in situ hybridization, DNA and RNA isolation and amplification, and real time, quantitative, and in situ PCR, as well as training in the application of these techniques; 6) Pathology Peer Review (including Pathology Data Review [PDR], Audit of Pathology Specimens [APS], Quality Assessment of pathology evaluations and Pathology Working Group Coordination [QA/PWG]) and technical support for these activities; 7) pathology data entry; 8) presentation or publication of pathology data or techniques, or support for these activities; 9) on-site pathology support, and 10) administrative support for the laboratory animal medicine group. The following work was completed for the National Toxicology Program and the NIEHS on this contract in the past year: four PWGs; 2 histology projects, primary pathology evaluations for 3 immunotoxicity studies, pathological evaluation of 19 studies for in-house NIEHS projects, and preparation of 13 posters, journal publications, or other publications. In addition, there are many other projects for the NTP and NIEHS that are in progress. The support person performing tasks for the laboratory animal group has worked full-time for the year being reported.
签订主题合同的目的是提供广泛的常规和专业病理学服务,以支持国家毒理学计划 (NTP) 根据合同进行的研究以及对通过这些研究产生的病理标本的补充研究。该合同还为 NIEHS 内部研究人员进行的研究和其他 NIEHS 合同研究提供关键病理学(包括分子病理学)支持。具体来说,本合同支持以下服务: 1) 尸检和内部尸检协助; 2) 组织学(组织修剪和处理、玻片制备和染色); 3)组织病理学评估/解释; 4)应用专门的定性和定量形态学程序(免疫组织化学、形态计量学、细胞增殖、凋亡、电子显微镜); 5) 细胞和分子生物学新技术的适应、开发、完善和应用,包括(但不限于)基因分型、DNA测序、原位杂交、DNA和RNA分离和扩增,以及实时、定量和原位PCR,以及这些技术应用的培训; 6) 病理学同行评审(包括病理学数据评审[PDR]、病理标本审核[APS]、病理学评估质量评估和病理学工作组协调[QA/PWG])以及对这些活动的技术支持; 7) 病理数据录入; 8) 病理数据或技术的呈现或出版,或对这些活动的支持; 9) 现场病理学支持,以及 10) 实验动物医学组的行政支持。去年,国家毒理学计划和 NIEHS 就该合同完成了以下工作:四个 PWG; 2 个组织学项目、3 项免疫毒性研究的主要病理学评估、内部 NIEHS 项目的 19 项研究的病理学评估,以及准备 13 份海报、期刊出版物或其他出版物。此外,NTP 和 NIEHS 还有许多其他项目正在进行中。为实验动物组执行任务的支持人员在报告的年份中一直全职工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES MORRISON其他文献
JAMES MORRISON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES MORRISON', 18)}}的其他基金
PATHOLOGY PEER REVIEW AND PATHOLOGY SUPPORT FOR THE DNTP AND DIR AT NIEHS" CHARLES RIVER LABORATORIES (CRL)
NIEHS 查尔斯河实验室 (CRL) 的 DNTP 和 DIR 的病理学同行评审和病理学支持
- 批准号:
10909759 - 财政年份:2015
- 资助金额:
$ 254.86万 - 项目类别:
Charles River Laboratories (CRL); Contract:HHSN273201500012C ; FY15 funding to fund the base contract award; CAN 8010787; IGF::OT::IGF:: Pathology Peer Review & Pathology Support for DNTP & DIR at NIE
查尔斯河实验室 (CRL);
- 批准号:
9161869 - 财政年份:2015
- 资助金额:
$ 254.86万 - 项目类别:
PATHOLOGY SUPPORT FOR THE NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
国家环境健康科学研究所的病理学支持
- 批准号:
8845123 - 财政年份:2014
- 资助金额:
$ 254.86万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 254.86万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 254.86万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 254.86万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 254.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 254.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 254.86万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 254.86万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 254.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 254.86万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 254.86万 - 项目类别:
Discovery Grants Program - Individual